{"id":"ademetionine-2","safety":{"commonSideEffects":[{"rate":null,"effect":"Gastrointestinal disturbances (nausea, diarrhea)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ademetionine (also known as S-adenosyl methionine or SAM) is an endogenous compound that serves as the primary methyl donor in cells. It participates in critical methylation reactions involving proteins, lipids, and nucleic acids, and is particularly important for hepatocyte membrane integrity and liver regeneration. By restoring depleted SAM levels, ademetionine supports liver function and may reduce cholestasis and hepatocellular damage.","oneSentence":"Ademetionine is a methyl donor that replenishes cellular S-adenosylmethionine (SAM) levels to support methylation reactions and hepatic function.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:26:42.947Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cholestasis and cholestatic liver disease"},{"name":"Hepatic dysfunction and liver support"},{"name":"Drug-induced liver injury"}]},"trialDetails":[{"nctId":"NCT07495995","phase":"PHASE2","title":"Single-Center Phase II Double-Blind Trial of SAMe to Prevent Liver Cancer in MASLD-Related Cirrhosis","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-04-15","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)","enrollment":94},{"nctId":"NCT07367724","phase":"PHASE2","title":"Ademetionine in Obstructive Hypertrophic Cardiomyopathy","status":"RECRUITING","sponsor":"China National Center for Cardiovascular Diseases","startDate":"2026-01-01","conditions":"Obstructive Hypertrophic Cardiomyopathy (oHCM)","enrollment":44},{"nctId":"NCT06258525","phase":"PHASE2","title":"SAMe in Prevention of Oxaliplatin-associated Liver Injury","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-03","conditions":"Colorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer","enrollment":30},{"nctId":"NCT06922669","phase":"NA","title":"Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-06-24","conditions":"Drug Induced Liver Injury","enrollment":232},{"nctId":"NCT04240990","phase":"NA","title":"Development of a Diagnostic Prediction Score for Tuberculosis in Hospitalized Children With Severe Acute Malnutrition (TB-Speed SAM)","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2019-11-04","conditions":"Tuberculosis, Severe Acute Malnutrition","enrollment":603},{"nctId":"NCT04250259","phase":"PHASE2","title":"SAMe Trial for Patients With Alcoholic Cirrhosis","status":"RECRUITING","sponsor":"Indiana University","startDate":"2020-10-22","conditions":"Alcoholic Cirrhosis","enrollment":196},{"nctId":"NCT06893471","phase":"NA","title":"From Yearly Checks to Daily Progress: Evaluating Goal Attainment Scaling (GAS) in Systematic Work Environment Management (SAM) Within the Municipal Sector","status":"ENROLLING_BY_INVITATION","sponsor":"Karolinska Institutet","startDate":"2024-08-15","conditions":"Behavior Change Interventions, Work Environment Adverse Effects, Health Factors","enrollment":45},{"nctId":"NCT07070856","phase":"NA","title":"Trial of Rice-Based F-75 in Severe Malnutrition & Persistent Diarrhea in Children (SAM-RICE Study)","status":"COMPLETED","sponsor":"Children's Hospital and Institute of Child Health, Multan","startDate":"2024-12-31","conditions":"Severe Acute Malnutrition, Persistent Diarrhea, Children","enrollment":320},{"nctId":"NCT07068191","phase":"NA","title":"Gepaktiv vs UDCA and Ademetionine in MAFLD With Hepatomegaly","status":"RECRUITING","sponsor":"Phenomen Pharma","startDate":"2025-06-19","conditions":"Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD), Hepatomegaly, Nonalcoholic Fatty Liver (NAFL)","enrollment":90},{"nctId":"NCT05363020","phase":"PHASE4","title":"S-Asenosyl-L-Methionine vs Placebo for Osteoarthritis of the Hands","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2022-08-17","conditions":"Osteoarthritis Hand","enrollment":40},{"nctId":"NCT06026865","phase":"NA","title":"S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Warsaw","startDate":"2023-08-01","conditions":"Primary Sclerosing Cholangitis (PSC)","enrollment":60},{"nctId":"NCT04981067","phase":"NA","title":"Dose-finding Study: Popliteal Sciatic Nerve Block in Patients Undergoing Diabetic Foot Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Seoul National University Hospital","startDate":"2021-08-24","conditions":"Diabetic Foot, Diabetic Neuropathies","enrollment":45},{"nctId":"NCT02835313","phase":"NA","title":"Promoting Recovery Optimization With WALKing Exercise After Stroke","status":"COMPLETED","sponsor":"University of Delaware","startDate":"2016-07-18","conditions":"Stroke","enrollment":250},{"nctId":"NCT02647385","phase":"NA","title":"Pain Control in Breast Surgery: Analgesia, Opioid Consumption and Inflammatory Response Evaluation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital Sirio-Libanes","startDate":"2015-12","conditions":"Breast Cancer, Anesthesia","enrollment":50},{"nctId":"NCT01899521","phase":"NA","title":"Examination of Zinc, S-adenosylmethionine, and Combination Therapy Versus Placebo in Alcoholics","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2013-05-01","conditions":"Alcoholism","enrollment":113},{"nctId":"NCT05586139","phase":"NA","title":"Microbiome-Directed Food for Sustained Recovery From Acute Malnutrition","status":"NOT_YET_RECRUITING","sponsor":"Institut de Recherche en Sciences de la Sante, Burkina Faso","startDate":"2024-10","conditions":"Acute Malnutrition With no Complications","enrollment":6200},{"nctId":"NCT03266146","phase":"PHASE1, PHASE2","title":"36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI","status":"COMPLETED","sponsor":"Beijing 302 Hospital","startDate":"2017-09-02","conditions":"Drug-induced Liver Injury,Chronic","enrollment":90},{"nctId":"NCT03766048","phase":"NA","title":"LAparoscopic Preventive PRErectal Mesh","status":"UNKNOWN","sponsor":"University Hospital, Lille","startDate":"2019-09-11","conditions":"Urogenital Prolapse","enrollment":834},{"nctId":"NCT05701553","phase":"","title":"Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2023-01-26","conditions":"Hepatocellular Carcinoma","enrollment":20},{"nctId":"NCT04313348","phase":"NA","title":"Patient-centered Mobile Technology Interventions to Improve Maternal Health in Uganda","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2020-08-01","conditions":"Maternal Child Health","enrollment":170},{"nctId":"NCT03721679","phase":"PHASE1, PHASE2","title":"Poly-ICLC (Hiltonol) and Anti-PD1 or Anti-PD-L1","status":"TERMINATED","sponsor":"Oncovir, Inc.","startDate":"2018-09-25","conditions":"Solid Cancer","enrollment":7},{"nctId":"NCT04623034","phase":"PHASE1","title":"Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine","status":"COMPLETED","sponsor":"MSI Methylation Sciences, Inc.","startDate":"2013-04-17","conditions":"Major Depressive Disorder","enrollment":34},{"nctId":"NCT02651350","phase":"PHASE1, PHASE2","title":"Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI","status":"COMPLETED","sponsor":"Beijing 302 Hospital","startDate":"2015-12","conditions":"Drug-induced Liver Injury,Chronic","enrollment":80},{"nctId":"NCT02592434","phase":"PHASE3","title":"Efficacy Study Of Tofacitinib In Pediatric JIA Population","status":"COMPLETED","sponsor":"Pfizer","startDate":"2016-06-10","conditions":"Juvenile Idiopathic Arthritis","enrollment":225},{"nctId":"NCT02231333","phase":"NA","title":"The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis","status":"COMPLETED","sponsor":"Institute of Liver and Biliary Sciences, India","startDate":"2013-07-01","conditions":"Non-alcoholic Steatohepatitis","enrollment":122},{"nctId":"NCT01806870","phase":"NA","title":"Immune Enhancement for Immunological Non-responders to ART","status":"COMPLETED","sponsor":"Emory University","startDate":"2013-03","conditions":"HIV","enrollment":30},{"nctId":"NCT02264860","phase":"NA","title":"Researching Alveolar Macrophage Improvements With Supplements in HIV","status":"COMPLETED","sponsor":"Emory University","startDate":"2014-10","conditions":"HIV-1 Infection","enrollment":67},{"nctId":"NCT03863002","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure","status":"UNKNOWN","sponsor":"Tianjin Weikai Bioeng., Ltd.","startDate":"2019-10-01","conditions":"Liver Failure, Acute on Chronic","enrollment":45},{"nctId":"NCT00762268","phase":"NA","title":"A Trial of SAMe for Treatment-Resistant Bipolar Depression","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2008-09","conditions":"Bipolar Disorder, Depression, Bipolar Depression","enrollment":23},{"nctId":"NCT00694564","phase":"NA","title":"Evaluation of S-adenosyl Methionine (SAM-e) for Recurrent Abdominal Pain in Children","status":"COMPLETED","sponsor":"Huang, Jeannie, M.D.","startDate":"2007-06","conditions":"Abdominal Pain","enrollment":8},{"nctId":"NCT00473200","phase":"PHASE1","title":"Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine","status":"COMPLETED","sponsor":"Baylor Research Institute","startDate":"2009-08","conditions":"Hyperhomocysteinemia","enrollment":27},{"nctId":"NCT00125281","phase":"PHASE2","title":"SAMe to Treat Biliary Cirrhosis Symptoms","status":"TERMINATED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2005-07-25","conditions":"Liver Cirrhosis, Biliary","enrollment":50},{"nctId":"NCT03178929","phase":"NA","title":"Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma","status":"UNKNOWN","sponsor":"Beijing Insight Science & Technology Co. Ltd.","startDate":"2017-07-01","conditions":"Primary Liver Cancer","enrollment":207},{"nctId":"NCT00573313","phase":"PHASE3","title":"Effects of SAMe in Patients With Alcoholic Liver Disease","status":"COMPLETED","sponsor":"University of California, Davis","startDate":"2005-09","conditions":"Liver Disease, Alcoholic","enrollment":94},{"nctId":"NCT00101452","phase":"NA","title":"Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression","status":"COMPLETED","sponsor":"Maurizio Fava, MD","startDate":"2005-04","conditions":"Depression","enrollment":199},{"nctId":"NCT02557360","phase":"PHASE4","title":"Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis","status":"COMPLETED","sponsor":"Pomeranian Medical University Szczecin","startDate":"2015-11","conditions":"Primary Biliary Cirrhosis","enrollment":24},{"nctId":"NCT00070941","phase":"PHASE2, PHASE3","title":"SAM-e for the Treatment of Depression in Patients With Parkinson's Disease","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2003-07","conditions":"Parkinson's Disease, Depression","enrollment":29},{"nctId":"NCT02586285","phase":"PHASE1","title":"Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Eastern Hepatobiliary Surgery Hospital","startDate":"2015-06","conditions":"Hepatocellular Carcinoma","enrollment":300},{"nctId":"NCT01912196","phase":"PHASE2","title":"Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)","status":"COMPLETED","sponsor":"MSI Methylation Sciences, Inc.","startDate":"2013-10","conditions":"Major Depressive Disorder (MDD)","enrollment":376},{"nctId":"NCT01320527","phase":"PHASE2","title":"A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2008-08","conditions":"Alzheimer's Disease, Mild Cognitive Impairment","enrollment":135},{"nctId":"NCT01754714","phase":"PHASE3","title":"Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group","status":"COMPLETED","sponsor":"Abbott","startDate":"2012-12","conditions":"Non Alcoholic Fatty Liver Disease","enrollment":108},{"nctId":"NCT02200029","phase":"PHASE3","title":"Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption","status":"COMPLETED","sponsor":"Abbott","startDate":"2014-06","conditions":"Intrahepatic Cholestasis Associated With Alcoholic Liver Disease","enrollment":75},{"nctId":"NCT00093847","phase":"PHASE2","title":"Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2004-05","conditions":"Depression","enrollment":73},{"nctId":"NCT01998620","phase":"PHASE4","title":"Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis","status":"UNKNOWN","sponsor":"Zhejiang Hisun Pharmaceutical Co. Ltd.","startDate":"2013-11","conditions":"Hepatitis B, Cholestasis","enrollment":240},{"nctId":"NCT02024295","phase":"PHASE4","title":"Efficacy and Safety of S-adenosyl-l-methionine in Treatment of Alcoholic Hepatitis With Cholestasis","status":"UNKNOWN","sponsor":"Zhejiang Hisun Pharmaceutical Co. Ltd.","startDate":"2013-12","conditions":"Hepatitis, Alcoholic","enrollment":118},{"nctId":"NCT01917734","phase":"","title":"Integrated Program for Children With Severe Acute Malnutrition in Madhya Pradesh, India","status":"COMPLETED","sponsor":"Victor M. Aguayo","startDate":"2010-01","conditions":"Severe Malnutrition","enrollment":2740},{"nctId":"NCT00475176","phase":"PHASE2","title":"S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2007-05","conditions":"Chronic Hepatitis C","enrollment":24},{"nctId":"NCT00379444","phase":"PHASE1, PHASE2","title":"Tobacco Cessation Treatment for Pregnant Alaska Natives","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2006-11","conditions":"Tobacco Use","enrollment":35},{"nctId":"NCT00903695","phase":"PHASE2","title":"MemoryXL Effects on Mild Cognitive Impairment Patients","status":"TERMINATED","sponsor":"University of Oklahoma","startDate":"2009-06","conditions":"Mild Cognitive Impairment","enrollment":10},{"nctId":"NCT00284011","phase":"NA","title":"Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2005-06","conditions":"Heart Disease","enrollment":52},{"nctId":"NCT00722124","phase":"PHASE2, PHASE3","title":"S-Adenosyl-L-Methionine (SAMe) for Smoking Abstinence","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-09","conditions":"Tobacco Dependence","enrollment":150},{"nctId":"NCT00310336","phase":"PHASE2, PHASE3","title":"Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2006-08","conditions":"Hepatitis C","enrollment":30},{"nctId":"NCT00108589","phase":"PHASE3","title":"S-Adenosylmethionine Therapy for Non-Alcoholic Steatohepatitis","status":"COMPLETED","sponsor":"US Department of Veterans Affairs","startDate":"2004-01","conditions":"Hepatitis","enrollment":""},{"nctId":"NCT00528710","phase":"PHASE2","title":"Efficacy of S-Adenosylmethionine in Fibromyalgia","status":"COMPLETED","sponsor":"Deakin University","startDate":"2006-11","conditions":"Fibromyalgia Syndrome","enrollment":70}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3623,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ademetionine 2","genericName":"Ademetionine 2","companyName":"Zhejiang Hisun Pharmaceutical Co. Ltd.","companyId":"zhejiang-hisun-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ademetionine is a methyl donor that replenishes cellular S-adenosylmethionine (SAM) levels to support methylation reactions and hepatic function. Used for Cholestasis and cholestatic liver disease, Hepatic dysfunction and liver support, Drug-induced liver injury.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}